President & Chief Operating Officer
South San Francisco California UNITED STATES
Dr. Trombley became President and Chief Operating Officer in September 2018 and has served as NGM's Chief Operating Officer since June 2015. Prior to that, Dr. Trombley was head of Business Development between 2011 and 2015. She was most recently at Novartis in Basel, Switzerland, where she was Chief of Staff for the Chief Executive Officer and worked on key corporate initiatives and strategic projects across the company’s healthcare businesses. Earlier in her career, Dr. Trombley worked at XenoPort, Inc., and at McKinsey & Company, where she advised pharmaceutical and medical device clients on strategic, commercial and operational issues. Dr. Trombley has served as a director of Carmot Therapeutics, Inc. since 2016. She received a B.S. in Chemistry from the University of California, San Diego and a Ph.D. in Chemistry from MIT.
None yet.